Jaids-Journal of Acquired Immune Deficiency Syndromes

Papers
(The H4-Index of Jaids-Journal of Acquired Immune Deficiency Syndromes is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037)105
Trends in the Uptake of Index Testing Among Adolescents in USAID-Supported President's Emergency Plan for AIDS Relief Programs, October 2017–September 202299
Breastfeeding Among Women Living With HIV in the Era of Lifelong ART: An Observational Multicountry Study in Eastern and Southern Africa40
The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment40
Clinician Perspectives on Disclosing Public Health Uses of HIV Antiretroviral Resistance Testing Results36
Supplemental Issue of the Journal of the Acquired Immune Deficiency Syndromes (JAIDS): The Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI)32
HIV Testing Among Transgender and Other Gender-Diverse Persons in the United States: A Scoping Review32
Cost and Cost-Effectiveness of Online Recruitment to Increase HIV Self-Testing Among Black and Hispanic/Latino Men Who Have Sex With Men in the United States, 2020–202128
Brief Report: Validation of the D:A:D Chronic Kidney Disease Risk Score Incorporating Proteinuria in People Living With HIV in Harare, Zimbabwe28
Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method28
Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study27
Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants—11 Sub-Saharan African Countries, 2015–201825
Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis25
National Impact of SARS-CoV-2 Infection on HIV Virological Suppression in South Africa22
Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV22
Predictors of Injection Visit Adherence in Those Receiving Injectable Cabotegravir/Rilpivirine21
Structural Equation Modeling of Stigma and HIV Prevention Clinical Services Among Transgender and Gender Diverse Adults: The Mediating Role of Substance Use and HIV Sexual Risk21
Patterns of HIV Treatment Preferences Among People With Diverse Demographic, Social, and Behavioral Characteristics Who Are Living With HIV in the United States21
Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials21
Evaluating the Impact of Blood–Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders20
0.81037187576294